Close Menu
Home » Mayo Tells Supreme Court Congress Should Clarify Patent Eligibility Confusion in Diagnostics

Mayo Tells Supreme Court Congress Should Clarify Patent Eligibility Confusion in Diagnostics

Nov 25, 2019
|
Turna Ray
Premium

This article has been corrected from a previous version to note that Athena Diagnostics filed its writ of certiorari with the Supreme Court, not the Court of Appeals for the Federal Circuit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

For Scientific Talent

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

Agency Pick Worries Brazilian Researchers

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

Speedy Work

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

PLOS Papers Include Greenlander BMI GWAS, Metabolic MicroRNA Marker Search, More

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more. 

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.